Silvia Donnici Garcia

Title: The Innovative Contributions of Silvia Donnici Garcia

Introduction

Silvia Donnici Garcia is a notable inventor based in Castellbisbal-Barcelona, Spain. She has made significant strides in the field of pharmaceutical innovations, particularly in the stabilization of micronized glycopyrronium salts. Her work has implications for the treatment of respiratory diseases, showcasing her commitment to improving patient care.

Latest Patents

Silvia holds a patent for a process that stabilizes the particle size of micronized glycopyrronium salt, specifically glycopyrronium bromide. This innovative process results in a micronized product that exhibits enhanced chemical and polymorphic stability, even after prolonged storage. The invention also encompasses compositions that include the stabilized glycopyrronium salt, as well as dry powder inhaler devices and capsules or blisters containing the stabilized product. These advancements are particularly relevant for treating conditions such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis.

Career Highlights

Silvia is currently associated with Inke, S.A., where she continues to develop her innovative ideas. Her dedication to research and development has positioned her as a key player in her field. With her expertise, she contributes to the advancement of pharmaceutical technologies that can significantly impact patient outcomes.

Collaborations

Silvia collaborates with esteemed colleagues, including Josep Terradas Camins and Josep Maria Carulla Oliver. These partnerships enhance her research efforts and foster a collaborative environment for innovation.

Conclusion

Silvia Donnici Garcia's contributions to the field of pharmaceutical inventions are noteworthy. Her patented process for stabilizing glycopyrronium salts represents a significant advancement in respiratory disease treatment. Through her work, she continues to make a positive impact on healthcare and patient well-being.